Announcements Trials

Browse Landscape

Sponsor

Conditions

Prostatic Neoplasms 2 Metastatic Hormone-sensitive Prostate Cancer 1

Interventions

Trastuzumab 9 Capecitabine 7 trastuzumab deruxtecan 6 Paclitaxel 6 Fulvestrant 6 pertuzumab 5 eribulin 5 Gemcitabine 4 Cyclophosphamide 4 sacituzumab govitecan 3 Vinorelbine 3 Doxorubicin 3 Docetaxel 3 Ado-Trastuzumab Emtansine 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 palbociclib 2 olaparib 2 larotrectinib 2 exemestane 2 abemaciclib 2 Fluorouracil 2 Epirubicin 2 Carboplatin 2 ulixertinib 1 tucatinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 taxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × Androgen Antagonists × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡